FDA.reportPublic FDA data

Vir Combination

Product NDC
43742-2040
Requested package NDC
43742-2040-1
11-digit product format
437422040
Labeler code
43742
Product ID
43742-2040_730cbe69-d67d-4041-bb71-46cc2829bcda
Type
HUMAN OTC DRUG
Nonproprietary name
Influenzinum (2021-2022), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode
Dosage form
LIQUID
Route
ORAL
Labeler
Deseret Biologicals, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2022-02-02
Marketing end
2027-08-23
Substance
HEPATITIS B VIRUS; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 6; INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)
Active strength
33; 12; 12; 15; 15; 16; 18; 15; 12; 12; 12; 12 [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
Pharmacologic classes
Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Live Human Adenovirus Type 7 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]
NDC exclude flag
No
Current FDA listing
Yes

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Vir CombinationINFLUENZINUM (2021-2022), HERPES SIMPLEX 1 NOSODE, HERPES SIMPLEX 2 NOSODE, HUMAN HERPESVIRUS 6A, HUMAN HERPESVIRUS 6B, CYTOMEGALOVIRUS NOSODE, HEPATITIS B NOSODE, ADENOVIREN NOSODE, EPSTEIN-BARR VIRUS NOSODEDeseret Biologicals, Inc.b5275aba-df1f-4ee9-adcd-41021cf3df582022-12-07WarningsExact identifier
ndc (package): 43742-2040-1
ndc (product): 43742-2040
ndc11 (package): 43742204001

Additional Listing Data#

Finished product
Yes
Brand name base
Vir Combination

Active Ingredients#

Ingredient, Strength table
IngredientStrength
INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)33 [hp_X]/mL
INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_C]/mL
INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_C]/mL
INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)15 [hp_X]/mL
HUMAN HERPESVIRUS 115 [hp_X]/mL
HUMAN HERPESVIRUS 216 [hp_C]/mL
HUMAN HERPESVIRUS 618 [hp_X]/mL
HUMAN HERPESVIRUS 515 [hp_X]/mL
HEPATITIS B VIRUS12 [hp_X]/mL
HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN12 [hp_X]/mL
HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN12 [hp_X]/mL
HUMAN HERPESVIRUS 412 [hp_X]/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 12 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
WD5E5VYM2EInternal UNII lookup
V529EJB2CXInternal UNII lookup
VEH9U90EHXInternal UNII lookup
B93BQX9789Internal UNII lookup
22G38P19RLInternal UNII lookup
74J6DNH49UInternal UNII lookup
4IX4VP35CRInternal UNII lookup
7COI029E6KInternal UNII lookup
77H9EM77P7Internal UNII lookup
FKD3DUK39IInternal UNII lookup
TM54L796SNInternal UNII lookup
2A26YW7PNXInternal UNII lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
b5275aba-df1f-4ee9-adcd-41021cf3df58Available on FDA.report

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
43742-2040-1Vir Combination30 mL in 1 BOTTLE, DROPPERLIQUID303

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
43742-2040VIR COMBINATION (INFLUENZINUM (2021-2022), HERPES SIMPLEX 1 NOSODE, HERPES SIMPLEX 2 NOSODE, HUMAN HERPESVIRUS 6A, HUMAN HERPESVIRUS 6B, CYTOMEGALOVIRUS NOSODE, HEPATITIS B NOSODE, ADENOVIREN NOSODE, EPSTEIN-BARR VIRUS NOSODE) LIQUID [DESERET BIOLOGICALS, INC.]3Current NDC, Legacy NDC, 1 package rows20221209_b5275aba-df1f-4ee9-adcd-41021cf3df58.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
43742-2040-14374220400130 mL in 1 BOTTLE, DROPPER (43742-2040-1) 30 ml2022-02-022027-08-23NoNoCurrent